132 related articles for article (PubMed ID: 1772997)
1. Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina.
Daví G; Violi F; Catalano I; Giammarresi C; Putignano E; Nicolosi G; Barbagallo M; Notarbartolo A
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):41-5. PubMed ID: 1772997
[TBL] [Abstract][Full Text] [Related]
2. Effects of defibrotide on fibrinolytic activity in diabetic patients with stable angina pectoris.
Davì G; Catalano I; Belvedere M; Amato S; Mogavero A; Giammarresi C; Alaimo P; Notarbartolo A
Thromb Res; 1992 Jan; 65(2):211-20. PubMed ID: 1579896
[TBL] [Abstract][Full Text] [Related]
3. Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris.
de Maat MP; de Bart AC; Hennis BC; Meijer P; Havelaar AC; Mulder PG; Kluft C
Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1156-62. PubMed ID: 8792769
[TBL] [Abstract][Full Text] [Related]
4. Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus.
Morishita E; Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Hashimoto T; Matsuda T
Atherosclerosis; 1996 Feb; 120(1-2):7-14. PubMed ID: 8645373
[TBL] [Abstract][Full Text] [Related]
5. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor activity as a possible indicator of disease activity in rest angina with angiographically insignificant coronary artery stenosis.
Sakata K; Kurata C; Kobayashi A; Rydzewski A; Yamazaki N
Thromb Res; 1991 Sep; 63(5):491-502. PubMed ID: 1755002
[TBL] [Abstract][Full Text] [Related]
7. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
8. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
9. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
Uchida Y
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 levels in patients with chronic angina pectoris with or without angiographic evidence of coronary sclerosis.
Huber K; Resch I; Stefenelli T; Lang I; Probst P; Kaindl F; Binder BR
Thromb Haemost; 1990 Jun; 63(3):336-9. PubMed ID: 2119522
[TBL] [Abstract][Full Text] [Related]
11. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
[TBL] [Abstract][Full Text] [Related]
12. Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis.
Mustonen P; Lepäntalo M; Lassila R
Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):244-9. PubMed ID: 9484989
[TBL] [Abstract][Full Text] [Related]
13. [Tissue-type plasminogen activator and its inhibitor (PAI-1) in plasma in cases of non-insulin-dependent diabetes mellitus (NIDDM)].
Jokaji H; Asakura H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Nihon Ronen Igakkai Zasshi; 1990 Nov; 27(6):699-705. PubMed ID: 2127812
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic activity is similar in physically active men with and without a history of myocardial infarction.
Fernhall B; Szymanski LM; Gorman PA; Milani J; Paup DC; Kessler CM
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1106-13. PubMed ID: 9194761
[TBL] [Abstract][Full Text] [Related]
15. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
[TBL] [Abstract][Full Text] [Related]
16. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
17. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
McBane RD; Hardison RM; Sobel BE;
Am J Cardiol; 2010 Jan; 105(1):17-24. PubMed ID: 20102884
[TBL] [Abstract][Full Text] [Related]
18. Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris.
Hoffmeister HM; Jur M; Wendel HP; Heller W; Seipel L
Circulation; 1995 May; 91(10):2520-7. PubMed ID: 7743613
[TBL] [Abstract][Full Text] [Related]
19. Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors.
Speiser W; Speiser P; Minar E; Korninger C; Niessner H; Huber K; Schernthaner G; Ehringer H; Lechner K
Thromb Res; 1990 Jul; 59(1):77-88. PubMed ID: 2144671
[TBL] [Abstract][Full Text] [Related]
20. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]